NEW YORK, June 7, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sprinklr, Inc. (“Sprinklr” or the “Company”) (NYSE: CXM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
Month: June 2024
NEW YORK, June 7, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Charge Enterprises, Inc. (NASDAQ: CRGE) (OTC: CRGEQ) between December 15, 2021 and February 28, 2024,…
NEW YORK, June 7, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Charge Enterprises, Inc. (NASDAQ: CRGE) (OTC: CRGEQ) between December 15, 2021 and February 28, 2024,…
Union Urges Governor Hochul Sign Bill to Keep Warehouse Workers Safe ALBANY, N.Y., June 7, 2024 /PRNewswire/ — The New York State Legislature passed new legislation today, championed by the New York State Conference of Teamsters, requiring Amazon and other major warehouse operators to…
Union Urges Governor Hochul Sign Bill to Keep Warehouse Workers Safe ALBANY, N.Y., June 7, 2024 /PRNewswire/ — The New York State Legislature passed new legislation today, championed by the New York State Conference of Teamsters, requiring Amazon and other major warehouse operators to…
NEW YORK, June 7, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Globe Life Inc. f/k/a Torchmark Corporation (NYSE: GL) between May 8, 2019 and April 10, 2024, both dates inclusive (the “Class Period”), of the important…
NEW YORK, June 7, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Enphase Energy, Inc. (NASDAQ: ENPH) between February 7, 2023 and April 25, 2023, both dates inclusive (the…
NEW YORK, June 7, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Exscientia p.l.c (NASDAQ: EXAI) between March 23, 2022 and February 12, 2024, both dates inclusive (the “Class Period”), of the important June 25, 2024 lead…
– CStone anuncia que el CHMP de la Agencia Europea de Medicamentos recomienda la aprobación de Cejemly® (sugemalimab, anti-PD-L1) como tratamiento de primera línea para el NSCLC La recomendación del CHMP de la EMA se basa en los resultados de un ensayo clínico de fase 3 (GEMSTONE-302) que…
Die CHMP-Empfehlung der EMA stützt sich auf die Ergebnisse einer klinischen Phase-3-Studie (GEMSTONE-302), die signifikante Vorteile für das progressionsfreie Überleben (rogression-Free Survival, PFS) und das Gesamtüberleben (Overall Survival, OS) von Sugemalimab in Kombination mit…